, , 1996.
, , 1996.
, , 1997.
Institute of Technology, 2005. ,
, , 2009.
, , 2011.
, Americain Psychiatric Association. DSM-III-R, Manuel diagnostique et statistique des troubles mentaux, 1987.
, Americain Psychiatric Association. DSM-5, Manuel diagnostique et statistique des toubles mentaux, 2015.
Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease, Am J Psychiatry. août, vol.167, issue.8, pp.899-914, 2010. ,
A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis, Psychoneuroendocrinology. mai, vol.38, issue.5, pp.603-614, 2013. ,
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry, vol.59, pp.449-56, 2002. ,
Sparse representation based biomarker selection for schizophrenia with integrated analysis of fMRI and SNPs, Neuroimage, vol.102, issue.1, pp.220-228, 2014. ,
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders, Prog Neurobiol. nov, vol.122, pp.45-72, 2014. ,
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset, Transl Psychiatry. 14 juill, vol.5, p.601, 2015. ,
Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression, Schizophr Bull. janv, vol.37, issue.1, pp.177-88, 2011. ,
The early symptoms of schizophrenia, Br J Psychiatry. mars, vol.112, issue.484, pp.225-51, 1966. ,
,
, , vol.39, pp.49-56, 2013.
Salivary cortisol in early psychosis: New findings and meta-analysis, Psychoneuroendocrinology. janv, vol.63, pp.262-70, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01312810
Prodromal interventions for schizophrenia vulnerability: the risks of being « at risk, Schizophr Res. 1 mars, vol.73, issue.2-3, pp.173-84, 2005. ,
Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?, Am J Psychiatry. janv, vol.157, issue.1, pp.60-66, 2000. ,
A randomised controlled trial of prophylactic neuroleptic treatment, Br J Psychiatry. févr, vol.148, pp.120-127, 1986. ,
Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset, Am J Psychiatry. juill, vol.152, issue.7, pp.967-72, 1995. ,
The neurodevelopmental hypothesis of schizophrenia, revisited, Schizophr Bull. mai, vol.35, issue.3, pp.528-576, 2009. ,
Cognitive and functional changes with aging in schizophrenia, Biol Psychiatry, vol.46, issue.7, pp.921-929, 1999. ,
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis, Arch Gen Psychiatry. sept, vol.68, issue.9, pp.881-90, 2011. ,
The psychosis high-risk state: a comprehensive state-ofthe-art review, JAMA Psychiatry. janv, vol.70, issue.1, pp.107-127, 2013. ,
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis, Neurosci Biobehav Rev, vol.31, issue.4, pp.465-84, 2007. ,
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies, vol.38, pp.1297-307, 2012. ,
Psychiatrie de l'enfant, de l'adolescent et de l'adulte. 2ème édition. Masson, 2009. ,
Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology, vol.49, pp.187-206, 2014. ,
,
, Encephale. avr, vol.30, issue.2, pp.109-127, 2004.
,
, Encephale. avr, vol.27, issue.2, pp.143-150, 2001.
ABC Schizophrenia study: an overview of results since 1996, Soc Psychiatry Psychiatr Epidemiol. juill, vol.48, issue.7, pp.1021-1052, 2013. ,
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence, Neuropsychology. juill, vol.12, issue.3, pp.426-471, 1998. ,
Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia, Am J Psychiatry, vol.157, issue.11, pp.1824-1832, 2000. ,
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study, Am J Psychiatry. déc, vol.168, issue.12, pp.1311-1318, 2011. ,
A systematic review and meta-analysis of recovery in schizophrenia, Schizophr Bull, vol.39, issue.6, pp.1296-306, 2013. ,
Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity, Compr Psychiatry. août, vol.36, issue.4, pp.241-50, 1995. ,
Signes précoces de schizophrénie: Des prodromes à la notion de prévention. Dunod, 2015. ,
Évaluation des états mentaux à risque de transition psychotique : validation de la version française de la CAARMS, L'Encéphale. déc, vol.40, issue.6, pp.447-56, 2014. ,
Neurological soft signs and schizophrenia: a review of current knowledge, Rev Neurol (Paris). déc, vol.163, issue.12, pp.1157-68, 2007. ,
Pourquoi et comment soigner plus précocement les troubles psychotiques ? La Presse Médicale, 2016. ,
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review, Arch Gen Psychiatry. sept, vol.62, issue.9, pp.975-83, 2005. ,
Early intervention for psychosis, Cochrane Database Syst Rev. 15 juin, issue.6, p.4718, 2011. ,
Modulation of brain network parameters associated with subclinical psychotic symptoms, Progress in Neuro-Psychopharmacology and Biological Psychiatry. 3 avr, vol.66, pp.54-62, 2016. ,
DOI : 10.1016/j.pnpbp.2015.11.010
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry, vol.46, pp.899-907, 1999. ,
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study, Arch Gen Psychiatry. mai, vol.68, issue.5, pp.489-95, 2011. ,
Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies, Schizophr Res. 1 avr, vol.60, issue.2-3, pp.239-58, 2003. ,
DOI : 10.1016/s0920-9964(02)00234-7
Clinique de l'enfance d'une population d'adultes schizophrènes. Étude rétrospective à propos de 50 cas. Neuropsychiatrie de l'Enfance et de l'Adolescence, vol.60, pp.526-559, 2012. ,
Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?, Curr Drug Saf. janv, vol.4, issue.1, pp.84-93, 2009. ,
DOI : 10.2174/157488609787354387
URL : http://www.benthamscience.com/cds/samples/cds4-1/0013CDS.pdf
Neurodevelopmental hypothesis of schizophrenia, Br J Psychiatry. mars, vol.198, issue.3, pp.173-178, 2011. ,
DOI : 10.1192/bjp.bp.110.084384
URL : https://www.cambridge.org/core/services/aop-cambridge-core/content/view/193CA07A34E8188E7B324541EA601547/S000712500025441Xa.pdf/div-class-title-neurodevelopmental-hypothesis-of-schizophrenia-div.pdf
Is it possible to be schizophrenic yet neuropsychologically normal?, Neuropsychology. juill, vol.11, issue.3, pp.437-483, 1997. ,
DOI : 10.1037/0894-4105.11.3.437
Neuroanatomical abnormalities before and after onset of psychosis: a crosssectional and longitudinal MRI comparison, Lancet. 25 janv, vol.361, issue.9354, pp.281-289, 2003. ,
DOI : 10.1016/s0140-6736(03)12323-9
URL : http://midag.cs.unc.edu/pubs/papers/Lancet-Schizo.pdf
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis, Am J Psychiatry, vol.162, issue.10, pp.1785-804, 2005. ,
Schizophrénie : évaluation du coût de la prise en charge, Journal d'économie médicale. 13 sept, vol.27, issue.7, pp.421-454, 2013. ,
,
, , vol.40, pp.380-386, 2014.
La schizophrénie de l'adulte, des causes aux traitements, 2006. ,
Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort, J Psychiatr Res, vol.42, issue.12, pp.982-90, 2008. ,
, Biological insights from 108 schizophrenia-associated genetic loci, Schizophrenia Working Group of the Psychiatric Genomics Consortium, vol.511, pp.421-428, 2014.
EPA guidance on the early intervention in clinical high risk states of psychoses, Eur Psychiatry. mars, vol.30, issue.3, pp.388-404, 2015. ,
Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort, Schizophr Bull. janv, vol.40, issue.1, pp.143-51, 2014. ,
Common variants on chromosome 6p22.1 are associated with schizophrenia, Nature. 6 août, vol.460, issue.7256, pp.753-760, 2009. ,
Psychopharmacologie essentielle, bases neuroscientifiques et applications pratiques. 4ème édition, 2015. ,
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume, Biol Psychiatry. 15 sept, vol.66, issue.6, pp.533-542, 2009. ,
Genetic architectures of psychiatric disorders: the emerging picture and its implications, Nat Rev Genet. 10 juill, vol.13, issue.8, pp.537-51, 2012. ,
DOI : 10.1038/nrg3240
URL : http://europepmc.org/articles/pmc4110909?pdf=render
Hypothèse neuro-développementale de la schizophrénie, L'Encéphale, vol.32, issue.5, pp.879-82, 2006. ,
The Antecedents of Schizophrenia: A Review of Birth Cohort Studies, Schizophr Bull. mai, vol.35, issue.3, pp.603-626, 2009. ,
Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia, Biol Psychiatry, vol.70, issue.7, pp.619-644, 2011. ,
Research review: Polygenic methods and their application to psychiatric traits, J Child Psychol Psychiatry, vol.55, issue.10, pp.1068-87, 2014. ,
DOI : 10.1111/jcpp.12295
Functional brain network analysis of schizophrenic patients with positive and negative syndrome based on mutual information of EEG time series, Biomedical Signal Processing and Control. janv, vol.31, pp.331-339, 2017. ,
Validation of « prodromal » criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up, Schizophr Res, vol.105, issue.1-3, pp.10-17, 2008. ,
, World Health Organization, Mental Health Atlas, vol.544, 2005.